NOVUS THERAPEUTICS INC's ticker is NVUS and the CUSIP is 67011N105. A total of 17 filers reported holding NOVUS THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $67,000 | – | 13,377 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,785,000 | $818,000 | 0.05% |
| Orbimed Advisors | 3,183,314 | $1,459,000 | 0.02% |
| Virtu Financial LLC | 92,113 | $42,000 | 0.01% |
| Bayesian Capital Management, LP | 11,601 | $5,000 | 0.00% |
| Private Advisor Group, LLC | 111 | $0 | 0.00% |
| JANE STREET GROUP, LLC | 42,134 | $19,000 | 0.00% |
| ROYAL BANK OF CANADA | 442 | $0 | 0.00% |
| Rockefeller Capital Management L.P. | 30,000 | $14,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 70 | $0 | 0.00% |
| NORTHERN TRUST CORP | 11,527 | $5,000 | 0.00% |